Artificial neural network technologies to identify biomarkers for therapeutic intervention

Current Opinion in Molecular Therapeutics

Volumn 6, Issue 6, 2004, Pages 616-623

  Bicciato, Silvio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Artificial neural network; Bioinformatics; Biomarker; Genotyping; Microarrays; Proteomics

Indexed keywords

BIOLOGICAL MARKER;

ARTIFICIAL NEURAL NETWORK; BIOSTATISTICS; COMPUTER ANALYSIS; DNA MICROARRAY; DRUG DESIGN; GENE TARGETING; HIGH THROUGHPUT SCREENING; HUMAN; INFORMATION PROCESSING; MASS SPECTROMETRY; PHYSIOLOGY; PREDICTION; PROTEIN MICROARRAY; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; GENE EXPRESSION PROFILING; HUMANS; NEURAL NETWORKS (COMPUTER);

EID: 11344276089     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. The chipping forecast I. Nat Genet (1999) 21 1 Suppl):1-60.
2. The chipping forecast II. Nat Genet(2002) 32 Suppl):461-552.
3. Quackenbush J: Computational analysis of microarray data. Nat Rev Genet (2001) 2(6):418-427.
4. Ringner M, Peterson C, Khan J: Analyzing array data using supervised methods. Pharmacogenomics (2002) 3(3 ):403-415.
5. Valafar F: Pattern recognition techniques in microarray data analysis: A survey. Ann NY Acad Sci (2002) 980:41-64.
6. Shannon W, Culverhouse R, Duncan J: Analyzing microarray data using cluster analysis. Pharmacogenomics (2003) 4 1):41-52.
7. Rumelhart DE, Hinton GE, Williams RJ: Learning internal representations by error propagation. In: Parallel Distributed Processing: Explorations in the Microstructure of Cognition: Foundations. Rumelhart DE, McClelland JL, The PDP Research Group (Eds), MIT Press, Cambridge, MA, USA (1986) 1.
8. Bishop CM: Neural netwonks for pattern recognition. Oxford University Press, Oxford, UK (1995).
9. Almeida. JS: Predictive non-linear modeling of complex data by artificial neural networks. Curr Opin Biotechnol (2002) 13(1):72-76.
10. Gerhold DL, Jensen RV, Gullans SR: Better therapeutics through microarrays. Nat Genet (2002) 32(Suppl ):547-551.
11. Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C, Meltzer PS: Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med (2001) 7 6):673-679.
12. He YD, Friend SH: Microarrays - the 21st century divining rod? Nat Med (2001) 7(6):658-659.
13. Xu Y, Selaru FM, Yin J, Zou TT, Shustova V, Mori Y, Sato F, Liu TC, Olaru A, Wang S, Kimos MC et al: Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. Cancer Res (2002) 62(12):3493-3497.
14. Selaru FM, Xu Y, Yin J, Zou T, Liu TC, Mori Y, Abraham JM, Sato F, Wang S, Twigg C, Olaru A et al: Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. Gastroenterology (2002) 122(3):606-613.
15. Azuaje F: Genomic data sampling and its effect on classification performance assessment. BMC Bioinformatics (2003) 4(1):5. http://www.biomedcentral.com/1471-2105/4/5
16. Berrar DP, Downes CS, Dubitzky W: Multiclass cancer classification using gene expression profiling and probabilistic neural networks. Pac Symp Biocomput (2003) 8:5-16.
17. Linder R, Dew D, Sudhoff H, Theegarten D, Remberger K, Poppl SJ, Wagner M: The 'subsequent artificial neural network' (SANN) approach might bring more classificatory power to ANN-based DNA microarray analyses. Bioinformatics (2004):doi:10.1093/bioinformatics/bth441.
18. Liu B, Cui Q, Jiang T, Ma S: A combinational feature selection and ensemble neural network method for classification of gene expression data. BMC Bioinformatics (2004) 5(1):136.
19. Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A, Ferno M, Peterson C, Meltzer PS: Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res (2001) 61(16):5979-5984.
20. Grey SR, Dlay SS, Leone BE, Cajone F, Sherbet GV: Prediction of nodal spread of breast cancer by using artificial neural network-based analyses of S100A4, nm23 and steroid receptor expression. Clin Exp Metastasis (2003) 20(6):507-514.
21. Bloom G, Yang IV, Boulware D, Kwong KY, Coppola D, Eschrich S, Quackenbush J, Yeatman TJ: Multi-platform, multi-site, microarray-based human tumor classification. Am J Pathol (2004) 164(1):9-16.
22. Tham CK, Heng CK, Chin WC: Predicting risk of coronary artery disease from DNA microarray-based genotyping using neural networks and other statistical analysis tool. J Bioinform Comput Biol (2003) 1(3):521-539.
23. Gruvberger-Saal SK, Eden P, Ringner M, Baldetorp B, Chebil G, Borg A, Ferno M, Peterson C, Meltzer PS: Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles. Mol Cancer Ther (2004) 3(2):161-168.
24. Wei JS, Greer BT, Westermann F, Steinberg SM, Son CG, Chen QR, Whiteford CC, Bilke S, Krasnoselsky AL, Cenacchi N, Catchpoole D et al: Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer Res (2004) 64(19):6883-6891.
25. O'Neill MC, Song L: Neural network analysis of lymphoma microarray data: Prognosis and diagnosis near-perfect. BMC Bioinformatics (2003) 4(1):13.
26. Bicciato S, Pandin M, Didonè G, Di Bello C: Pattern identification and classification in gene expression data using an autoassociative neural network model. Biotechnol Bioeng (2003) 81(5):594-606.
27. Curtis D, North BV, Sham PC: Use of an artificial neural network to detect association between a disease and multiple marker genotypes. Ann Hum Genet (2001) 65(1):95-107.
28. North BV, Curtis D, Cassell PG, Hitman GA, Sham PC: Assessing optimal neural network architecture for identifying disease-associated multi-marker genotypes using a permutation test, and application to calpain 10 polymorphisms associated with diabetes. Ann Hum Genet (2003) 67(4):348-356.
29. Spicker JS, Wikman F, Lu ML, Cordon-Cardo C, Workman C, ORntoft TF, Brunak S, Knudsen S: Neural network predicts sequence of TP53 gene based on DNA chip. Bioinformatics (2002) 18 8):1133-1134.
30. Hsia TC, Chiang HC, Chiang D, Hang LW, Tsai FJ, Chen WC: Prediction of survival in surgical unresectable lung cancer by artificial neural networks including genetic polymorphisms and clinical parameters. J Clin Lab Anal (2003) 17(6):229-234.
31. Tomita Y, Tomida S, Hasegawa Y, Suzuki Y, Shirakawa T, Kobayashi T, Honda H: Artificial neural network approach for selection of susceptible single nucleotide polymorphisms and construction of prediction model on childhood allergic asthma. BMC Bioinformatics (2004) 5(1):120.
32. Petricoin EF, Liotta LA: Clinical applications of proteomics. J Nutr (2003) 133(7 Suppl):2476S-2484S.
33. Bensmail H, Haoudi A: Postgenomics: Proteomics and bioinformatics in cancer research. J Biomed Biotechnol (2003) 2003(4):217-230.
34. Ball G, Mian S, Holding F, Allibone RO, Lowe J, Ali S, Li G, McCardle S, Ellis IO, Creaser C, Rees RC: An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid Identification of potential biomarkers. Bioinformatics (2002) 18(3):395-404.
35. Rogers MA, Clarke P, Noble J, Munro NP, Paul A, Selby PJ, Banks RE: Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: Identification of key issues affecting potential clinical utility. Cancer Res (2003) 63(20):6971-6983.
36. Baczek T, Bucinski A, Ivanov AR, Kaliszan R: Artificial neural network analysis for evaluation of peptide MS/MS spectra in proteomics. Anal Chem (2004) 76(6):1726-1732.
37. Yu JK, Chen YD, Zheng S: An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics. World J Gastroenterol (2004) 10(21 :3127-3131.